Health Matters | India Mustn’t Take Shortcuts for Making Biosimilars, Confusing Affordability with Efficacy Bad Idea

Generics and biosimilars warrant separate strategies and approaches. The Centre needs to ensure tighter controls before approval and periodic quality checks to ensure every batch shows consistent quality